← Eichor
Condition: Liver Cirrhosis Alcoholic Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Liver Cirrhosis Alcoholic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
Phase 2 · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06599918Faecal Microbiota Transplantation for Liver Cirrhosis
Phase 2/Phase 3 · 1 location(s) · University of Aarhus · NCT04932577Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
Phase N/A · 1 location(s) · German Diabetes Center · NCT05046483A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 317 location(s) · 89bio, Inc. · NCT06419374InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
Phase N/A · 3 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT04190849Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
Phase 4 · 1 location(s) · Getz Pharma · NCT05644717Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NA · 1 location(s) · Maja Thiele · NCT03308916Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients W
Phase N/A · 9 location(s) · University Hospital, Lille · NCT04106518PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT04371042Digoxin In NASH (CODIN)
Phase 2 · 2 location(s) · Yale University · NCT06588699LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · 444 location(s) · Boehringer Ingelheim · NCT06632457Efficacy of Simvastatin in Alcoholic Liver Fibrosis
Phase 2/Phase 3 · 1 location(s) · Anna Cruceta · NCT04971577Fibrosis Lessens After Metabolic Surgery
Phase 4 · 22 location(s) · Ali Aminian · NCT06374875"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chron
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04690972LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or A
Phase 3 · 525 location(s) · Boehringer Ingelheim · NCT06632444Liver Damage and Cardiometabolic Disorders in NAFLD
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04036357The European NAFLD Registry
Phase N/A · 37 location(s) · Newcastle University · NCT04442334SAMe Trial for Patients With Alcoholic Cirrhosis
Phase 2 · 2 location(s) · Indiana University · NCT04250259Evaluating the Pharmacokinetics and Safety of Miricorilant
Phase 1 · 1 location(s) · Corcept Therapeutics · NCT07553663Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis
Phase N/A · 1 location(s) · Hannover Medical School · NCT07169526Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis
NA · 1 location(s) · University of Bologna · NCT06308757A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Phase 3 · 23 location(s) · King's College London · NCT06461208Optimized Remission in Alcohol-related Liver Cirrhosis
NA · 1 location(s) · Copenhagen University Hospital, Hvidovre · NCT06866496An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and T
NA · 1 location(s) · Stephanie Gräger · NCT06814990Cardiac Dysfunction in Patients with Fatty Liver Disease
Phase N/A · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06386094Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease
NA · 2 location(s) · Khyber Medical University Peshawar · NCT07294963
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.